TY - JOUR
T1 - Coincident Regulation of PLCb Signaling by Gq-Coupled and l-Opioid Receptors Opposes Opioid-Mediated Antinociception
AU - Sanchez, Gissell A.
AU - Jutkiewicz, Emily M.
AU - Ingram, Susan
AU - Smrcka, Alan V.
N1 - Publisher Copyright:
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Pain management is an important problem worldwide. The current frontline approach for pain management is the use of opioid analgesics. The primary analgesic target of opioids is the l-opioid receptor (MOR). Deletion of phospholipase Cb3 (PLCb3) or selective inhibition of Gbc regulation of PLCb3 enhances the potency of the antinociceptive effects of morphine suggesting a novel strategy for achieving opioid-sparing effects. Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in human embryonic kidney 293 cells and found that MOR alone could not stimulate PLC but rather required a coincident signal from a Gq-coupled receptor. Knockout of PLCb3 or pharmacological inhibition of its upstream regulators, Gbc or Gq, ex vivo in periaqueductal gray slices increased the potency of the selective MOR agonist [D-Ala2, N-Me-Phe4, Gly5-ol]enkephalin acetate salt in inhibiting presynaptic GABA release. Finally, inhibition of Gq- G protein-coupled receptor coupling in mice enhanced the antinociceptive effects of morphine. These data support a model where Gq and Gbc-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency. Ultimately, this could lead to identification of new non-MOR targets that would allow for lower-dose utilization of opioid analgesics.
AB - Pain management is an important problem worldwide. The current frontline approach for pain management is the use of opioid analgesics. The primary analgesic target of opioids is the l-opioid receptor (MOR). Deletion of phospholipase Cb3 (PLCb3) or selective inhibition of Gbc regulation of PLCb3 enhances the potency of the antinociceptive effects of morphine suggesting a novel strategy for achieving opioid-sparing effects. Here we investigated a potential mechanism for regulation of PLC signaling downstream of MOR in human embryonic kidney 293 cells and found that MOR alone could not stimulate PLC but rather required a coincident signal from a Gq-coupled receptor. Knockout of PLCb3 or pharmacological inhibition of its upstream regulators, Gbc or Gq, ex vivo in periaqueductal gray slices increased the potency of the selective MOR agonist [D-Ala2, N-Me-Phe4, Gly5-ol]enkephalin acetate salt in inhibiting presynaptic GABA release. Finally, inhibition of Gq- G protein-coupled receptor coupling in mice enhanced the antinociceptive effects of morphine. These data support a model where Gq and Gbc-dependent signaling cooperatively regulate PLC activation to decrease MOR-dependent antinociceptive potency. Ultimately, this could lead to identification of new non-MOR targets that would allow for lower-dose utilization of opioid analgesics.
UR - http://www.scopus.com/inward/record.url?scp=85141935963&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85141935963&partnerID=8YFLogxK
U2 - 10.1124/molpharm.122.000541
DO - 10.1124/molpharm.122.000541
M3 - Article
C2 - 36116788
AN - SCOPUS:85141935963
SN - 0026-895X
VL - 102
SP - 269
EP - 279
JO - Molecular pharmacology
JF - Molecular pharmacology
IS - 6
ER -